BOSTON, MA / ACCESSWIRE / September 28, 2015 / Zoom Telephonics (OTCQB: ZMTP) (“the Company” or “Zoom”), a leading producer of cable modems and other communications products, today announced the closing on Friday September 25 of a non-brokered private placement (“the Offering”) of 4,909,999 unregistered shares at $0.70 per share for gross proceeds of $3.437 million.

Subsequent to closing, the current shares outstanding of the Company will be 13,271,303. The company anticipates filing an S-1 to register the shares sold in the offering. The purchased shares will not be eligible for sale until six months after the closing of the private placement.

Zoom plans to use the proceeds from the Offering for working capital to support the launch and anticipated significant sales of its Motorola brand cable modems. In May the Company announced that it had entered into an exclusive licensing agreement with Motorola for cable modem products for 5 years starting January 1, 2016.

This Offering was negotiated at arm’s length. The financing was led by Manchester Management, LLC. which together with its associates (collectively “Manchester”) owned 32.29% of the Company after closing of the private placement. Manchester is now an insider of the Company in accordance with applicable securities laws.

“It is rare to find an opportunity with a confluence of such an experienced and effective team and such a powerful brand and market opportunity. We are excited to be a part of the Zoom story,” said Morgan Frank, portfolio manager of Manchester.

“Zoom anticipates dramatic growth fueled by our Motorola brand cable modems, which are targeted for shipment starting January 2016,” said Frank Manning, Zoom’s President and CEO. “We have an aggressive product and marketing plan for these products, and the proceeds from this Offering will enable us to fuel our growth strategy. We are pleased to be working with Manchester Management, whose involvement goes beyond their significant investment and includes key business contacts.”

Additionally, Zoom and Manchester announced that Phil Frank and George Patterson have joined the Zoom Board.

Phil Frank (no relation to Morgan Frank) is a technology executive with over 20 years of experience. He spent a decade with the Nokia Corporation in a variety of senior roles, most recently as the Global Head of Corporate Development, focusing specifically on Nokia’s Network Infrastructure business. Prior to Nokia, Mr. Frank was responsible for network planning, strategy and M&A at AT&T Wireless and was intimately involved in the $31 billion acquisition of AT&T Wireless by Cingular. At global consulting firm DiamondCluster International, Mr. Frank was a leader in the North American high-tech consulting practice and served many leading communications and technology companies, both domestically and abroad. Mr. Frank’s operational and strategic experience on both the telecom equipment and carrier side of the communications business will be valuable as Zoom enters a new period of anticipated growth.

George Patterson is an investment banking professional with 17 years of experience. From July 2013 to July 2015 he served as the Co-Head of Software, Systems and Solutions Investment Banking at Barclays Investment Bank, based in New York. From January 2009 to June 2013, Mr. Patterson was Head of Technology Investment Banking, EMEA for Barclays, based in London. Prior to Barclays’ acquisition of Lehman Brothers’ North American operations in late 2008, he worked in the Technology investment banking group at Lehman Brothers, which he joined in 2000. During his tenure as an investment banker, Mr. Patterson has worked on a wide variety of equity, fixed income, and M&A transactions for many corporate and private equity clients across the technology ecosystem in North America, EMEA and the Asia Pacific. His experience and familiarity with the technology industry will add unique perspective to Zoom’s board of directors.

Conference Call Today At 11:00 a.m. Eastern Time

Zoom has scheduled a conference call for Monday September 28 at 11:00 a.m. Eastern Time. You may access the conference call by dialing toll free (866) 393-7958 if you are in the U.S., and international callers may dial (706) 643-5255. The conference ID is 49684657. Shortly after the conference call, a recording of the call will be available on Zoom’s website at www.zoomtel.com/investor .

About Zoom Telephonics

Founded in 1977 in Boston, Zoom Telephonics, Inc. designs, produces, markets, and supports cable modems and other communication products. For more information about Zoom and its products, please see www.zoomtel.com.

MOTOROLA and the Stylized M Logo are trademarks or registered trademarks of Motorola Trademark Holdings, LLC. and are used under license.

Forward Looking Statements

This release contains forward-looking information relating to Zoom Telephonics’ plans, expectations, and intentions. Actual results may be materially different from expectations as a result of known and unknown risks, including: the potential need for additional funding which Zoom may be unable to obtain; delays, unanticipated costs, interruptions or other uncertainties associated with Zoom’s production and shipping; Zoom’s reliance on several key outsourcing partners; uncertainty of key customers’ plans and orders; risks relating to product certifications; Zoom’s dependence on key employees; uncertainty of new product development, including budget overruns, project delays, and the risk that newly introduced products may contain undetected errors or defects or otherwise not perform as anticipated; costs and senior management distractions due to patent-related matters; and other risks set forth in Zoom’s filings with the Securities and Exchange Commission. Zoom cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Zoom expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Zoom’s expectations or any change in events, conditions or circumstance on which any such statement is based.

Investor Relations Contact Information

John Nesbett/Jennifer Belodeau
Institutional Marketing Services (IMS)
Phone: 203.972.9200
jnesbett@institutionalms.com

SOURCE: Zoom Telephonics

ReleaseID: 432237

KELOWNA, BC / ACCESSWIRE / September 28, 2015 / Laguna Blends Inc. (the “Company” or “Laguna”) (CNSX: LAG) is pleased to announce that manufacturing has commenced for Laguna’s “Caffe” Protein Coffee. Laguna owns the intellectual property for this unique and proprietary product.

An initial purchase order has been placed with Laguna’s manufacturing partner PNP Pharmaceuticals, (“PNP”) to deliver 16,667 boxes of Caffe to Laguna within the next 8-10 weeks. Each box contains 30 units of protein coffee. Laguna has provided a 50% deposit towards the initial purchase order.

Laguna spent over one year of research and development to invent a completely unique product. Laguna has achieved its goal of creating a delicious tasting, functional beverage that is served hot as an instant coffee. Approximately 20% of the 6.2 grams per package contains whey and hemp protein, this makes Laguna’s product very different than its competition in the direct sales and retail coffee business.

Stuart Gray, President and CEO of Laguna states, “PNP Pharmaceuticals was a logical partner for Laguna Blends to manufacture our Caffe product. PNP has the highest quality manufacturing standards in Canada. Since PNP manufactures pharmaceuticals in addition to nutritional products they are required to meet additional quality standards that other manufacturers do not. Touring the facility and meeting the executives and staff involved provided me with the confidence that PNP could deliver the quality product standards that we require and that they are capable to ramp up production when necessary.”

Starbucks is the only company in the world that’s a major player with a protein coffee beverage. Starbucks product is a ready to serve cold protein Coffee in a can. Laguna’s protein Coffee is an instant, just add hot water protein coffee.

After water, the beverage that the largest proportion of adults reported consuming is Coffee. *According to the CAC’s newly released 2013 Canadian Coffee Drinking Study, coffee is a dominant beverage in the Canadian market. Only tap water enjoys equally high past-day penetration. The results of the research show that approximately two-thirds of adult Canadians (65%) consumed coffee in the past- day. Approximately three-quarters of Canadians aged 18-79 (78%) indicate they’ve consumed coffee in the past week. A total of 83% of Canadians say they’ve enjoyed coffee in the past-year. Coffee drinkers consume on average 3.2 cups of coffee per day. A cup of coffee before you exercise can boost performance, help you stay hydrated and reduce exercise related fatigue as well as deliver a number of other positive health impacts.

Glen North, President and CEO of PNP Pharmaceuticals Inc. said, “I am excited to have entered into a manufacturing agreement with Laguna Blends to be the exclusive manufacturer of their “Caffe” Protein Coffee product. We are thrilled to be involved with a company that is innovative as well as committed to offering products of the highest quality possible.”

About: PNP Pharmaceuticals Inc.
PNP Pharmaceuticals Inc. (PNP) is a leading Canadian contract manufacturer of pharmaceuticals, nutraceuticals products for export to markets worldwide. Founded in 1999, PNP has the expertise and high-volume production capabilities to formulate, blend, and package any dry dosage form (capsule, tablet, powders or bulk package for overseas transport) to the highest industry standards. PNP operates an ultra-modern 75,000 square foot manufacturing facility that meets or exceeds all “Good Manufacturing Practice” and is a leader in regulatory certifications and accreditations. PNP Pharmaceuticals is Health Canada Site Licensed, Establishment Licensed, NSF Sport and Dietary Certified, TGA Approved, Informed Choice, Halal and Organic Certified.

www.pnppharmaceuticals.com

About Laguna Blends Inc.
The Company’s business is focused on the nutritional health benefits derived from hemp. The Company is a network marketing direct sales company that intends to generate retail sales through independent affiliates. The Company’s affiliates utilize tools and technology that enable them to build an international business from their own home or while traveling. The first products to be launched by the Company are expected to be functional beverages that provide high levels of protein and/or nutrition.

The Company’s products are made from high quality hemp protein. Some of the Company’s current products are hemp coffee – coffee beverages that contain both whey and hemp protein. In addition, the Company plans to market a variety of unique single serving “on-the-go” hemp protein mixes with various flavours. The hemp proteins are water soluble and can be directly mixed in water or added to milk, almond milk or coconut milk. In addition, the hemp protein can be blended in a shake with fruit. The Company also plans to offer other product categories in the future. The Company intends to sell its products through its independent affiliates in the USA and Canada and anticipates launching its business in the fall of 2015.

ON BEHALF OF THE BOARD
“Stuart Gray” President, Chief Executive Officer, Chief Financial Officer and Director

*Canadian Coffee Drinking Study

http://www.coffeeassoc.com/contact-us/

Forward-Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws statements regarding the Company’s business, products and future plans including, without limitation, statements regarding the expected launch date for the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward- looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking 3 information in this news release. The statements in this news release are made as of the date of this release.

Contact:
Laguna Blends Inc.
#302 – 1912 Enterprise Way
Kelowna, B.C. V1Y 9S9
Stuart Gray, President, CEO, CFO and Director
Tel: 250.868.0787
lagunablendsceo@gmail.com
www.lagunablends.com

SOURCE: Laguna Blends Inc.

ReleaseID: 432252

MILWAUKEE, WI / ACCESSWIRE / September 28, 2015 / Telkonet, Inc. (OTCQB: TKOI), creator of the EcoSmart platform of in-room automation solutions integrated to optimize energy efficiency, comfort and data collection in support of the emerging Internet of Things (IoT) today announced that Kimpton(R) Hotels and Restaurants, the largest chain of boutique hotels in the United States, recently adopted the EcoSmart platform at a second property, the Hotel Marlowe in Cambridge, Massachusetts, to be used in all of its guest rooms and suites to reduce energy expense. Kimpton Hotels is a hotel brand of InterContinental Hotels Group (NYSE:IHG), one of the world’s leading hotel companies with 724,018 rooms in more than 4,900 hotels in nearly 100 countries around the world.

“We’re pleased to expand our relationship with Kimpton Hotels, and grow our EcoSmart deployments to enable increased energy cost reductions,” said Jason Tienor, CEO of Telkonet, “Controlling energy consumption with the EcoSmart platform can make a significant impact on a property owner’s bottom line, as heating, ventilation and air conditioning costs represent a substantial portion of a facility’s overall utility bill.”

On average, America’s approximately 53,000 hotels spend $2,196 per available room each year on energy or about 6% of all operating costs. Through a strategic approach to energy efficiency, a 10% reduction in energy consumption would have the same financial effect as increasing the average daily room rate by $0.60 in limited-service hotels and by $2.00 in full-service hotels.

The fully networked system installed at Hotel Marlowe features Property Management System integration, BACNet integration, as well as the cloud-based EcoCentral Virtual Engineer intelligence engine and Telkonet’s leading EcoCare services which empower management and maintenance staff to proactively manage the HVAC systems throughout the property, address any issues quickly through maintenance triggers and SMS alerts, and remote access through the revolutionary EcoMobile application.

The EcoSmart Platform provides comprehensive savings, management reporting, analytics and virtual engineering of a customer’s portfolio and/or property’s room-by-room energy consumption. Telkonet has deployed more than a half million intelligent devices worldwide in properties within the hospitality, military, educational, healthcare and other commercial markets. The EcoSmart Platform is rapidly being recognized as a leading solution for reducing energy consumption, operational costs and carbon footprints, and eliminating the need for new energy generation in these marketplaces – all whilst improving occupant comfort and convenience.

ABOUT KIMPTON HOTELS & RESTAURANTS

San Francisco-based Kimpton Hotels & Restaurants is a leading collection of boutique hotels and restaurants and the acknowledged industry pioneer that first introduced the boutique hotel concept to the United States. In 1981, Bill Kimpton founded the company that today is renowned for making travelers feel genuinely cared for through thoughtful perks and amenities, bold, playful design and a sincerely personal style of guest service. Out to help people live full, balanced lives, Kimpton aims to inspire with touches like yoga mats in every room, complimentary coffee and tea to start the day, hosted evening Wine Hour, in-room fitness programming and complimentary bike rentals. The award-winning restaurants and bars are led by talented chefs and bartenders that offer guests a chance to dine like a local. Kimpton is consistently ranked as one of the top companies in the Market Metrix Hospitality Index, Upper Upscale Segment, for Customer Satisfaction. The company is highly-regarded for its innovative employee culture and benefits and has been named a FORTUNE magazine “Best Place to Work” six times since 2009. Kimpton is continuously growing and currently operates over 60 hotels and 70 plus restaurants, bars and lounges in 30 U.S. cities. In January 2015, Kimpton was welcomed into the InterContinental Hotels Group (IHG) family of hotel brands, bringing together two special cultures and sets of values to create the world’s largest boutique hotel business. For more information, visit www.KimptonHotels.com.

ABOUT TELKONET

Telkonet is a leading provider of intelligent automation solutions throughout commercial markets worldwide. The Internet of Things (IoT), offers considerable energy cost reductions, staff productivity enhancements and carbon footprint reductions through intelligent networked communications, improved asset utilization and data analytics. IoT platforms like Telkonet’s EcoSmart enable users to achieve savings, value and service through networked connectivity providing monitoring, control, analytics, convenience and the ability to participate with the emerging Smart Grid through automated demand response initiatives. Telkonet serves vertical markets that have established the company as a leading networking, efficiency and energy management technology provider. Those markets consist of Hospitality, Education, Military, Government, Healthcare and Public Housing. Telkonet’s business divisions include EcoSmart(TM), a networked automation platform featuring Recovery Time(TM) technology offering cost savings, energy reductions, optimized asset utilization and improved comfort, and EthoStream(R), one of the largest hospitality High-Speed Internet Access networks in the world providing public Internet access to more than 100 million annual users. www.telkonet.com

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company’s ability to obtain new contracts and accurately estimate net revenue due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company’s financial results, can be found in the Company’s Registration Statement and in its Reports on Forms 8-K filed with the Securities and Exchange Commission (SEC).

Media Contacts:

Telkonet Investor Relations
414.721.7988
ir@telkonet.com

SOURCE: Telkonet, Inc.

ReleaseID: 432168

NEWARK, DE / ACCESSWIRE / September 28, 2015 / Accurexa Inc. (the “Company”) (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that George Yu, MD, President & CEO, will present at the annual Partnering Forum, part of the Stem Cell Meeting on the Mesa to be held October 7-9 in La Jolla, California.

This conference is the sector’s premiere forum bringing together senior executives and top decision makers in the industry within the scientific community with the shared goal of advancing and translating cutting-edge research into revolutionary treatments and cures.

Co-hosted by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM) and the Sanford Consortium for Regenerative Medicine, the 2015 Stem Cell Meeting on the Mesa is a three-day conference featuring program’s two-day Partnering Forum, a Public Forum lecture and a full-day Scientific Symposium.

At the Partnering Forum, held October 7 and 8, industry executives will lead in-depth, interactive panels and workshops to discuss critical commercial issues facing the sector today.

The nationally recognized Scientific Symposium, held October 9 at the Salk Institute for Biological Studies, will showcase leading academic research in the field of regenerative medicine and advanced therapies.

Stem Cell Meeting on the Mesa is expected to attract nearly 800 attendees, including leading cell therapy, gene therapy and tissue engineering companies, large pharma and biotech, industry investors and major academic research institutions.

The following are specific details regarding Accurexa’s presentation at the conference:

Event: 2015 Stem Cell Meeting on the Mesa – Partnering Forum

Date: Wednesday, October 7, 2015

Time: 1:15pm Pacific Standard Time

Location: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037

A live video webcast of all company presentations will be available at: http://stemcellmeetingonthemesa.com/webcast/ and will also be published on ARM’s website shortly after the event.

Please visit http://stemcellmeetingonthemesa.com/ for full information including registration. Complimentary attendance at this event is available for credentialed investors and members of the media only. Investors should contact Laura Parsons at lparsons@alliancerm.org and interested media should contact Lyndsey Scull at lscull@alliancerm.org.

About Accurexa, Inc.

The Company is focused on developing novel neurological therapies to be directly delivered into specific regions of the brain. The company is developing its ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The ACX-31 program is based on an issued patent licensed from Accelerating Combination Therapies LLC which is co-owned by Dr. Henry Brem, Director of the Neurosurgery Department at Johns Hopkins University. The Company is collaborating in the development of its ACX-31 program with Dr. Henry Brem who built one of the largest brain tumor research and treatment centers in the world at Johns Hopkins University. Dr. Robert Langer, who is the David H. Koch Institute Professor at MIT and the most cited engineer in history, is also advising the Company in the development of its ACX-31 program. Both Dr. Brem and Dr. Langer are pioneers in the development of local drug delivery treatments, and invented and developed Gliadel(R) which is a FDA approved, local chemotherapy for the treatment of glioblastoma multiforme.

Oral temozolomide is a generic, FDA approved, first-line chemotherapy drug that is indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment. Before oral temozolomide became generic, it generated US sales of $420 million and global sales of $910 million under its brand name Temodar in 2012. However, current standard of care of delivering temozolomide to tumor sites through oral administration is limited by the blood-brain-barrier and oral temozolomide increases patient survival by 2.5 months from a 12.1 months median overall survival.

Animal studies at the Johns Hopkins School of Medicine(1) have shown that local delivery of temozolomide increased concentrations of the drug in the brain threefold and increased survival up to fourfold compared with oral administration. The percentage of long-term survivors for groups receiving local delivery of temozolomide ranged from 25% to 37.5% while there were no long-term survivors with orally administered temozolomide. Further animal studies at the Johns Hopkins School of Medicine(2) have shown that the additive effect of combined delivery of local temozolomide with local BCNU, especially in combination with radiotherapy, was significantly more effective than delivery of either drug alone or one systemically and one locally, either with or without radiation. Groups treated with combination of local temozolomide, local BCNU and radiation therapy had 75% long-term survivors.

The Company’s BranchPoint device was invented to deliver multiple therapeutics, such as stem cells, chemotherapy or gene therapy vectors, through the radial deployment of a flexible catheter to specific brain target areas through a single brain penetration, and licensed from UCSF (University of California, San Francisco). The current standard of care is the use of straight, rigid needles, often requiring surgeons to penetrate the brain multiple times for delivering therapeutics, which in turn may increase the risk of bleeding, stroke and reflux of therapeutics back out to the brain surface. An animal study at UCSF(3) demonstrated that the use of a straight needle was associated with reflux of at least 75% of the infusion while no reflux was found with the BranchPoint device. The development of the BranchPoint device was originally funded with $1.8 million by California’s Stem Cell Agency CIRM (California Institute of Regenerative Medicine). A 510(k) application was submitted to the FDA in June 2015.

Additional information about the Company may be found on its website, www.accurexa.com.

Notes:

(1) Brem S, Tyler BM, Li K, Pradilla G, Legnani F, Caplan J, et al. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother Pharmacol 2007; 60:643-50.

(2) Renard Recinos V, Tyler BM, Brem H, et al. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Neurosurgery 2010; 66:530-537.

(3) Silvestrini MT, Yin D, Coppes VG, Mann P, Martin AJ, Larson PS, Starr PA, Gupta N, Panter SS, Desai TA, Lim DA. Radially branched deployment for more efficient cell transplantation at the scale of the human brain. Stereotact Funct Neurosurg. 2013;91(2):92-103.

Safe Harbor Statement

This release contains certain “forward-looking statements” relating to the business of the Company. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the ability of the Company to successfully develop and commercialize novel neurological therapies based on its BranchPoint device or U.S. Patent No. 8,895,597 B2, or its ACX-31 program and execute its business plan; the business strategy, plans, and objectives of the Company; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume any duty to update these forward-looking statements.

Contact Investor Relations:

David Burke
The Ruth Group
Tel.: 646-536-7009
dburke@theruthgroup.com

Accurexa Inc.
info@accurexa.com
Tel.: 302-709-1822

SOURCE: Accurexa Inc.

ReleaseID: 432229

CORAL GABLES, FL / ACCESSWIRE / September 28, 2015 / Higher market volatility has brought rise to much more uncertainty when it comes to finding investment opportunity for investors & traders alike. As many have noted, foreign instability and lower interest rates remaining in place have been previous catalysts to conclusively leading investors down the path of smaller capitalization value investments. With the US economy strengthening, emerging companies have an opportunity to take advantage of the business climate. With three quarters nearly behind us, the fourth quarter has given rise to many of these small cap companies zeroing in on finishing 2015 strong. Companies like Maxima Group (PINKSHEETS: MXMG), Entertainment Arts Research Group, Inc. (PINKSHEETS: EARI), and Enviro-Serv Inc. (PINKSHEETS: EVSV) have found themselves working to increase the size of their respective operational footprints in order to build upon market momentum gained earlier in the year.

Maxima Group through a reverse merger with SMASH Solutions, the Company looks to provide software solutions that include social and SEO options for small businesses. In recent news SMASH and Vancouver based 4th Dimension Marketing, Inc. completed a strategic OEM partnership agreement to market the SMASH Booster Bar SEO product. This will be marketed under a white label name “SEO Rocket Bar”. Claude Walon of SMASH stated, “This is further validation that this product offers a unique value to SMB’s and warrants being introduced to a broader audience. This partnership further solidifies our mission of reaching and helping more companies compete effectively in an ever evolving digital world.”

Since hitting lows in June of $0.12, shares of MXMG have moved up as high as $1.55 during July. As of Friday’s close, MXMG ended the session at $0.18.

In similar fashion over recent weeks Entertainment Arts Research Inc. has also seen an increase in daily volume as well as price spikes by as much as 312.5% from lows of $0.04. Following the submission and filing of its second quarter financial, EARI released a shareholder update announcing plans for making new acquisitions of additional companies in order to further enhance its current offering of services such as web design, SEO, email & social media marketing, as well as SMS marketing. Mark Gibbs, President of EARI stated,” The companies we are talking to are all leaders in the their industry. They are attracted to being part of EARI because our vision encompasses where technology and informational marketing is headed. We are going to be a family of companies that not only provide services for a company to sell in social media but we will be one of the few that will be able to manage the entire business brand and its sales cycle. EARI is looking at filling a tremendous void of having a company not only design and optimize your website, but will also be able to coordinate our Client’s message in social and traditional marketing campaigns to deliver maximum and consistent brand recognition for a greater customer experience. We will provide our Clients with a suite of tools to manage the efficiency of their marketing and brand recognition efforts.”

Enviro-Serv made several announcements earlier this year regarding the finalization of the company’s subsidiary becoming part of the Pestmaster franchise. Since this time Enviro-Serv, through its subsidiary, Pestmaster Tampa (former: XTerminate), the company has realized a 30% increase in revenues versus that of a previous 20% estimate. Furthermore, the stock over the last several months has seen prices increase to highs of $0.0015, which was prior to EVSV making announcement regarding financial progress generated from the Pestmaster Tampa subsidiary. A market report (http://www.researchandmarkets.com/research/g2h9zc/global_pest) predicts an increase in pest control service revenue through 2016, and pesticide product category sales through 2019. Because of pest populations rising, pest control is predicted to continue to improve. Another prediction of improvement in the market is due to the rebound of the overall economy, meaning more people will be looking to construct houses and new build sites. Meanwhile pest control companies have been able to find gross margins that are upwards of 60% (http://www.paulweyland.com/gross_profit_margins.pdf).

ABOUT US:

www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts.

To subscribe by phone and receive messages directly to a mobile phone, text the phrase “StockAlerts” to 63566.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.

EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

CONTACT:

Company: DailyStockReporter.com
Contact Email: news@dailystockreporter.com

SOURCE: DailyStockReporter.com

ReleaseID: 432257